<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas14811-bib-0011">
 <label>11</label>
 <mixed-citation publication-type="journal" id="cas14811-cit-0011">
  <string-name>
   <surname>Hentic</surname>
   <given-names>O</given-names>
  </string-name>, 
  <string-name>
   <surname>Hammel</surname>
   <given-names>P</given-names>
  </string-name>, 
  <string-name>
   <surname>Couvelard</surname>
   <given-names>A</given-names>
  </string-name>, et al. 
  <article-title>FOLFIRI regimen: an effective second‐line chemotherapy after failure of etoposide‐platinum combination in patients with neuroendocrine carcinomas grade 3</article-title>. 
  <source xml:lang="en">Endocr Relat Cancer</source>. 
  <year>2012</year>;
  <volume>19</volume>:
  <fpage>751</fpage>‐
  <lpage>757</lpage>.
  <pub-id pub-id-type="pmid">22940375</pub-id>
 </mixed-citation>
</ref>
